Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

2022 Performance Bonus Payments

On December 14, 2022, the Compensation Committee (the Committee) of the Board of Directors of Eliem Therapeutics, Inc. (Eliem, or the Company) reviewed the achievement of Company and individual performance goals and other factors deemed relevant by the Committee in determining the amounts earned by Eliem's named executive officers under its performance bonus program for 2022. The following table sets forth the 2022 performance bonuses, which will be paid in 2023:



                                                                          2022
                                                                       Performance
Name and Principal Position                                            Bonus Award
Robert Azelby
President and Chief Executive Officer and Director                    $     438,750
Erin M. Lavelle
Chief Operating Officer/Chief Financial Officer                       $     209,588

Valerie Morisset, Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer

                                                    £     145,467

2023 Performance Bonus Program and Salary Increases

On December 14, 2022, the Committee approved annual base salaries and target bonus percentages for Eliem's 2023 performance bonus program for its named executive officers. The 2023 annual performance bonuses for each named executive officer, other than Mr. Azelby, will be based upon the achievement of Company performance goals and individual performance goals. Mr. Azelby's annual performance bonus will be based solely upon the achievement of Company performance goals. The Company performance goals will be established by the Board of Directors at a later date. The individual performance goals will consist of a subjective assessment of each named executive officer's individual contributions to Eliem. The following table sets forth the base salary and target performance bonus percentages for 2023:



                                                                             2023 Target
                                                                             Performance
                                                                              Bonus as
                                                                             Percentage
                                                         2023 Base               of
Name and Principal Position                                Salary            Base Salary
Robert Azelby
President and Chief Executive Officer and Director       $  702,000                    65 %
Erin M. Lavelle
Chief Operating Officer/Chief Financial Officer          $  484,380                    45 %

Valerie Morisset, Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer

                             £  336,190                    45 %

Additional information regarding compensation of Eliem's named executive officers, including the factors considered by the Committee in determining compensation, will be included in the proxy statement for Eliem's 2023 Annual Meeting of Stockholders.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses